Search results
TREMFYA® (guselkumab) QUASAR Maintenance Study in UC met its primary endpoint and all major...
FOX 23 News Albany· 4 days agoWASHINGTON, May 20, 2024 /PRNewswire/ -- Johnson & Johnson today announced the first data from the Phase 3 QUASAR Maintenance Study (Abstract #759) that showed 50.0 percent (p<0.001) of patients ...
Urine Tests Could Be 'Enormous Step' in Diagnosing Cancer
Medscape· 3 days agoThe next frontier in cancer detection could be the humble urine test. Emerging science suggests that...